Integrating Imaging and Liquid Biopsy to Monitor Cancer Treatment Response (R01)
This R01 opportunity supports clinical studies that combine in vivo molecular/functional imaging with fluid-based tumor monitoring (liquid biopsy) to assess treatment response, detect recurrence, and identify emerging resistance across cancer therapies. Projects must use assays already validated or in final validation and aim to define how combined modalities complement each other to improve c…
The purpose of this initiative is to support study design and integration of imaging and fluid-based tumor monitoring analyses into one or more therapeutic settings for assessing treatment success, failure or recurrence. The knowledge gained from this initiative is expected to capture dynamic ch…
Funding Source
Awards & funding
Eligibility
Foreign/Non-domestic eligibility: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed within applicat…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers